Clinical Trial Update: Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the effectiveness and safety of sequential cisplatin and docetaxel chemotherapy in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Ovarian Neoplasms | Phase 2 | Status: COMPLETED